Open AccesspH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)
Author(s) -
Helmut Deißler,
H Krammer,
Anton Gillessen
Publication year - 2021
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2021.1472
Subject(s) - mesalazine , ulcerative colitis , medicine , drug , gastroenterology , inflammatory bowel disease , drug delivery , adverse effect , colitis , pharmacology , disease , chemistry , organic chemistry